890 5th Avenue Partners, Inc. – 12/3/2021

BuzzFeed was founded by Jonah Peretti in 2005 with a focus on building a new media business model for the internet and social media world. 890 5th is a special purpose acquisition corporation, targeting a business in the media, digital media, consumer technology, interactive entertainment, and related industries, that raised $287.5 million through an initial…

G1 Therapeutics – 5/16/2017

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of novel small molecule therapeutics for the treatment of patients with cancer. The Company’s product pipeline currently includes three clinical-stage product candidates with the potential to significantly improve the treatment of patients with cancer. Trilaciclib and lerociclib are based on the…

Novus Capital Corporation II – 2/4/2021

Novus Capital Corp. II, is a blank check company newly formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Novus II’s management team will leverage experience bringing cutting edge companies to scale, to find a target and consummate a transaction.

Wireless Vision Holdings – 12/30/2020

Wireless Vision is the largest T-Mobile Exclusive Retailer in the country operating more than 600 T-Mobile-branded retail stores in 27 states. Established in 2004 and based in Bloomfield Hills, Michigan, the Company is dedicated to providing quality customer service while marketing a full suite of wireless, broadband and streaming products and services exclusively for T-Mobile,

Adaptimmune Therapeutics plc – 5/5/2015

Adaptimmune is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform. The Company aims to utilize the body’s own machinery – the T-cell to target and destroy cancer cells by using engineered, increased affinity T-cell receptors, or TCRs, as a means of…

Immunomedics, Inc. – 5/5/2017

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Immunomedics’ portfolio of investigational products includes antibody-drug conjugates (ADCs) that are designed to deliver a specific payload of a chemotherapeutic directly to the tumor while reducing overall toxicities that are usually found with…

Endeavour Silver Corp – 5/5/2016

Endeavour Silver Corp is a precious metal mining company. The company is primarily engaged in silver mining and owns three high-grade, underground, silver-gold mines in Mexico. Its other business activities include acquisition, exploration, development, extraction, processing, refining and reclamation. The company is organized into four operating mining segments, Guanacevi, Bolanitos, El Cubo, and El Compas,

NeoGenomics, Inc. – 5/5/2021

NeoGenomics, Inc. (“NeoGenomics” or the “Company”) is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers and others with innovative diagnostic, prognostic and predictive testing. NeoGenomics provides expert bone marrow and surgical pathology consulting. The Company has a network of CAP-accredited, CLIA-certified facilities in the U.S. and offers global…

Nuvei Corporation – 10/5/2021

Nuvei (the “Company”) is a global provider of payment technology solutions to merchants and partners in North America, Europe, Asia Pacific, and Latin America. Nuvei serves as a single source provider of omni-channel payments solutions to distribution partners and merchants, delivering a seamless, secure, and unified customer experience for in-store, online, and mobile commerce. The…

Digimarc – 8/5/2016

Digimarc Corporation enables governments and enterprises around the world to give digital identities to media and objects that computers can sense, recognize and then react to. The Company’s IP portfolio covers a range of methods, applications, system architectures and business processes and focuses on different methods for embedding and decoding digital information. The Company initially…

Dermira – 8/5/2015

Dermira is a biopharmaceutical company that identifies, develops, and commercializes novel therapies to treat dermatologic diseases with significant unmet need. In June 2018, the Company’s lead product candidate, Qbrexza, received FDA approval for the treatment of Primary Axillary Hyperhidrosis., a chronic skin condition affecting approximately 15 million people in the United States. The Company is…

Load More